Skip to content

Clinical trials

Phase 3 Embolism trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Embolism Phase: Phase 3 Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20051
20064
20082
20092
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ARCA Biopharma, Inc.2
Daiichi Sankyo Co., Ltd.2
Sanofi2
Assistance Publique - Hôpitaux de Paris1
Centre Hospitalier Universitaire de Nīmes1
Daiichi Sankyo1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
National Heart, Lung, and Blood Institute (NHLBI)1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Embolism12
Thrombosis7
Stroke4
Thromboembolism4
Venous Thrombosis4
Atrial Fibrillation3
Arterial Occlusive Diseases2
Intermittent Claudication2
Venous Thromboembolism2
Acute Coronary Syndrome1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.